QBiotics Group

Private

BrisbaneHealthcare & Life Scienceshttps://qbiotics.com/

Last Round

Private Placement

Jun 25, 2021

Est. Valuation

$328.91M

Momentum Score

25 /100

Company Overview

QBiotics Group is a life sciences company that discovers and develops novel small molecule pharmaceuticals from nature for human and animal health, with a focus on oncology and wound healing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small molecule pharmaceuticalsoncologytigilanol tiglatenatural product drug discoverySTELFONTA®solid tumor treatmentveterinary oncologybiodiscoveryvet-to-human developmentplant-derived pharmaceuticalsclinical-stage biotechintratumoral injectionwound healingpharmaceutical licensingtranslational medicinedrug discovery platformProtein Kinase C activator

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QBiotics Group Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

QBiotics Group Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jun 25, 2021
Private Placement	Jul 13, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Victoria Gordon

Chief Strategy Officer, Co-Founder & Executive Director

Founding Team

Ebru Davidson

Interim CEO And Managing Director, General Counsel

Executive Team

Stephen Doyle

Chief Executive Officer

Executive Team

Peter Schmidt

Chief Operating Officer

Executive Team

View all key people

QBiotics Group Investors

Notable investors and investment history

Investor	Rounds
TDM Growth Partners	Private Placement

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 19, 2026
Monthly visitors grew 164% MoM, reaching 5.3K.
Dec 19, 2024
Monthly visitors increased 708% MoM, reaching 10.5K.

View all signals

QBiotics Group Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

QBiotics Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about QBiotics Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrisbane

Employee Range31

Year Founded2000

Last FundingJun 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.